[go: up one dir, main page]

WO2012091946A3 - Method for inhibiting pathogens using a nutritional composition - Google Patents

Method for inhibiting pathogens using a nutritional composition Download PDF

Info

Publication number
WO2012091946A3
WO2012091946A3 PCT/US2011/065231 US2011065231W WO2012091946A3 WO 2012091946 A3 WO2012091946 A3 WO 2012091946A3 US 2011065231 W US2011065231 W US 2011065231W WO 2012091946 A3 WO2012091946 A3 WO 2012091946A3
Authority
WO
WIPO (PCT)
Prior art keywords
nutritional composition
inhibiting
inhibiting pathogens
human
pathogens
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2011/065231
Other languages
French (fr)
Other versions
WO2012091946A2 (en
Inventor
Anja Wittke
Cecilia MUNOZ
Dattatreya Banavara
Robert J. MCMAHON
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mead Johnson Nutrition Co
Original Assignee
Mead Johnson Nutrition Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US12/980,808 external-priority patent/US20120171163A1/en
Priority claimed from US12/980,813 external-priority patent/US8648036B2/en
Priority to EP11809005.9A priority Critical patent/EP2658388A2/en
Priority to MX2013006094A priority patent/MX2013006094A/en
Application filed by Mead Johnson Nutrition Co filed Critical Mead Johnson Nutrition Co
Priority to CA2822892A priority patent/CA2822892C/en
Priority to PH1/2013/500916A priority patent/PH12013500916A1/en
Priority to CN201180063052.8A priority patent/CN103327828B/en
Priority to BR112013011642A priority patent/BR112013011642B1/en
Priority to RU2013128920/15A priority patent/RU2013128920A/en
Priority to HK14102732.3A priority patent/HK1189456B/en
Priority to SG2013035944A priority patent/SG190781A1/en
Publication of WO2012091946A2 publication Critical patent/WO2012091946A2/en
Publication of WO2012091946A3 publication Critical patent/WO2012091946A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J1/00—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
    • A23J1/20—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from milk, e.g. casein; from whey
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pediatric Medicine (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

A method for inhibiting a bacterial invasive or adhesion mechanism involving administering to a human a nutritional composition including a lipid or fat; a protein source; a prebiotic composition; and at least about 10 mg/100kCal of lactoferrin produced by a non-human source.
PCT/US2011/065231 2010-12-29 2011-12-15 Method for inhibiting pathogens using a nutritional composition Ceased WO2012091946A2 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
HK14102732.3A HK1189456B (en) 2010-12-29 2011-12-15 Method for inhibiting pathogens using a nutritional composition
SG2013035944A SG190781A1 (en) 2010-12-29 2011-12-15 Method for inhibiting pathogens using a nutritional composition
RU2013128920/15A RU2013128920A (en) 2010-12-29 2011-12-15 METHOD FOR INHIBITING PATHOGENS USING A NUTRIENT COMPOSITION
EP11809005.9A EP2658388A2 (en) 2010-12-29 2011-12-15 Method for inhibiting pathogens using a nutritional composition
CA2822892A CA2822892C (en) 2010-12-29 2011-12-15 Method for inhibiting pathogens using a nutritional composition
PH1/2013/500916A PH12013500916A1 (en) 2010-12-29 2011-12-15 Method for inhibiting pathogens using a nutritional composition
CN201180063052.8A CN103327828B (en) 2010-12-29 2011-12-15 Use the method for nutritional composition in inhibiting pathogen
BR112013011642A BR112013011642B1 (en) 2010-12-29 2011-12-15 method for inhibiting pathogens using a nutritional composition
MX2013006094A MX2013006094A (en) 2010-12-29 2011-12-15 METHOD FOR INHIBITING PATHOGENS USING NUTRITIONAL COMPOSITION.

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US12/980,808 US20120171163A1 (en) 2010-12-29 2010-12-29 Method for inhibiting a bacterial invasive mechanism using a nutritional composition
US12/980,808 2010-12-29
US12/980,813 US8648036B2 (en) 2010-12-29 2010-12-29 Use of nutritional compositions including lactoferrin and one or more prebiotics in inhibiting adhesion of pathogens in the gastrointestinal tract
US12/980,813 2010-12-29

Publications (2)

Publication Number Publication Date
WO2012091946A2 WO2012091946A2 (en) 2012-07-05
WO2012091946A3 true WO2012091946A3 (en) 2012-09-07

Family

ID=45496273

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2011/065231 Ceased WO2012091946A2 (en) 2010-12-29 2011-12-15 Method for inhibiting pathogens using a nutritional composition

Country Status (13)

Country Link
EP (1) EP2658388A2 (en)
CN (1) CN103327828B (en)
BR (1) BR112013011642B1 (en)
CA (1) CA2822892C (en)
EC (1) ECSP13012798A (en)
MX (1) MX2013006094A (en)
MY (1) MY174494A (en)
PE (1) PE20141192A1 (en)
PH (1) PH12013500916A1 (en)
RU (1) RU2013128920A (en)
SG (2) SG190781A1 (en)
TW (1) TWI626893B (en)
WO (1) WO2012091946A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8968722B2 (en) 2010-12-29 2015-03-03 Mead Johnson Nutrition Company Milk-based nutritional compositions containing lactoferrin and uses thereof
AU2013364172B2 (en) * 2012-12-18 2016-12-08 Mjn U.S. Holdings Llc Milk-based nutritional compositions containing lactoferrin and uses thereof
US20140271978A1 (en) * 2013-03-15 2014-09-18 Mead Johnson Nutrition Company Low-buffer nutritional compositions and uses thereof
US9609888B2 (en) * 2013-07-31 2017-04-04 Mead Johnson Nutrition Company Nutritional compositions containing synergistic combination and uses thereof
EP3681511B1 (en) * 2017-09-10 2025-10-29 Technion Research & Development Foundation Limited Composition and method for a prebiotic delivery system targeted to probiotic bacteria
GB2618609A (en) * 2022-05-13 2023-11-15 Lintbells Ltd Methods and processes for manufacture of a topically adherent selective bactericide
WO2024056786A1 (en) 2022-09-14 2024-03-21 N.V. Nutricia Nutritional composition

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006121507A1 (en) * 2005-05-05 2006-11-16 Bristol-Myers Squibb Company Use of bovine lactoferrin in the manufacture of a medicament for inhibiting the growth of bacteria
US20080003329A1 (en) * 2006-06-30 2008-01-03 Ricardo Rueda Enriched infant formulas
WO2008047391A1 (en) * 2006-10-17 2008-04-24 S.I.F.Fr.A. Farmaceutici Srl Nutriceutic composition comprising lactoferrin and proteasic probiotics
WO2009068549A1 (en) * 2007-11-26 2009-06-04 Nestec S.A. Age-tailored nutrition system for infants
WO2009118771A2 (en) * 2008-03-26 2009-10-01 Paolo Manzoni Use of lactoferrin for prevention of neonatal sepses in premature newborns
WO2011051482A1 (en) * 2009-10-29 2011-05-05 Nestec S.A. Nutritional compositions comprising lactoferrin and probiotics and kits of parts thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE61701B1 (en) 1986-07-17 1994-11-30 Morinaga Milk Industry Co Ltd Process for producing bovine lactoferrin in high purity
US4977137B1 (en) * 1987-06-03 1994-06-28 Baylor College Medicine Lactoferrin as a dietary ingredient promoting the growth of the gastrointestinal tract
US5407957A (en) 1990-02-13 1995-04-18 Martek Corporation Production of docosahexaenoic acid by dinoflagellates
SG49307A1 (en) 1991-01-24 1998-05-18 Martek Corp Microbial oil mixtures and use thereof
US5374567A (en) 1993-05-20 1994-12-20 The United States Of America As Represented By The Secretary Of The Navy Operational amplifier using bipolar junction transistors in silicon-on-sapphire
WO1995022258A2 (en) 1994-02-16 1995-08-24 Pharming Bv Isolation of lactoferrin from milk
DK1480524T3 (en) 2002-03-07 2013-07-15 Upfront Chromatography As Method for isolating lactoferrin
CN101247823A (en) * 2005-05-05 2008-08-20 布里斯托尔-迈尔斯斯奎布公司 Use of bovine lactoferrin in the preparation of medicines for inhibiting bacterial growth
US7572474B2 (en) * 2005-06-01 2009-08-11 Mead Johnson Nutrition Company Method for simulating the functional attributes of human milk oligosaccharides in formula-fed infants
US8425955B2 (en) * 2009-02-12 2013-04-23 Mead Johnson Nutrition Company Nutritional composition with prebiotic component

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006121507A1 (en) * 2005-05-05 2006-11-16 Bristol-Myers Squibb Company Use of bovine lactoferrin in the manufacture of a medicament for inhibiting the growth of bacteria
US20080003329A1 (en) * 2006-06-30 2008-01-03 Ricardo Rueda Enriched infant formulas
WO2008047391A1 (en) * 2006-10-17 2008-04-24 S.I.F.Fr.A. Farmaceutici Srl Nutriceutic composition comprising lactoferrin and proteasic probiotics
WO2009068549A1 (en) * 2007-11-26 2009-06-04 Nestec S.A. Age-tailored nutrition system for infants
WO2009118771A2 (en) * 2008-03-26 2009-10-01 Paolo Manzoni Use of lactoferrin for prevention of neonatal sepses in premature newborns
WO2011051482A1 (en) * 2009-10-29 2011-05-05 Nestec S.A. Nutritional compositions comprising lactoferrin and probiotics and kits of parts thereof

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DATABASE GNPD [online] Mintel; January 2010 (2010-01-01), ANONYMOUS: "New birth formula", XP002673470, Database accession no. 1249000 *
DATABASE GNPD [online] Mintel; June 2010 (2010-06-01), ANONYMOUS: "Infant formula milk powder (stage 1)", XP002673469, Database accession no. 1337332 *
DATABASE GNPD [online] Mintel; September 2010 (2010-09-01), ANONYMOUS: "Stage 1 Baby formula powder", XP002673468, Database accession no. 1395602 *
NICOLA ORSI: "The antimicrobial activity of lactoferrin: Current status and perspectives", BIOMETALS, KLUWER ACADEMIC PUBLISHERS, BO, vol. 17, no. 3, 1 June 2004 (2004-06-01), pages 189 - 196, XP019232194, ISSN: 1572-8773, DOI: 10.1023/B:BIOM.0000027691.86757.E2 *

Also Published As

Publication number Publication date
BR112013011642A2 (en) 2016-07-12
SG190781A1 (en) 2013-07-31
TWI626893B (en) 2018-06-21
CN103327828A (en) 2013-09-25
EP2658388A2 (en) 2013-11-06
RU2013128920A (en) 2015-02-10
HK1189456A1 (en) 2014-06-13
WO2012091946A2 (en) 2012-07-05
PH12013500916A1 (en) 2024-06-03
BR112013011642B1 (en) 2020-04-07
TW201238503A (en) 2012-10-01
CA2822892A1 (en) 2012-07-05
CA2822892C (en) 2020-04-28
MX2013006094A (en) 2013-07-03
CN103327828B (en) 2016-05-11
PE20141192A1 (en) 2014-10-01
ECSP13012798A (en) 2013-09-30
SG10201508194RA (en) 2015-11-27
MY174494A (en) 2020-04-23

Similar Documents

Publication Publication Date Title
WO2012091946A3 (en) Method for inhibiting pathogens using a nutritional composition
IN2014DN03449A (en)
MX350325B (en) Bacterium for use as a probiotic for nutritional and medical applications.
MA33075B1 (en) Formulated to regulate lipid metabolism
WO2013028555A3 (en) Methods for weight loss and ketogenic compositions
PH12013501892A1 (en) Nutritional compositions including branched chain fatty acids for wound healing
MX342733B (en) Nutritional composition to promote healthy development and growth.
BR112014009418A2 (en) peptidomimetic macrocycles
BR112013028709A2 (en) bacterial strains capable of metabolizing oxalates
PH12012502318A1 (en) Substantially clear nutritional liquids comprising calcium hmb and soluble protein
WO2010007332A3 (en) Composition of branched maltodextrins and eukaryotic organisms having a polysaccharide wall, used in the field of well-being
MX2012012616A (en) Methods and compositions for inducing satiety.
WO2012142413A3 (en) Nitrite compositions and uses thereof
WO2010019212A3 (en) Methods for enhancing energy metabolism
BR112014027820A2 (en) dietary control of celiac disease and food allergies
PH12014500796A1 (en) Partially hydrolyzed casein-whey nutritional compositions for reducing the onset of allergies
MY161933A (en) Fortified Milk-Based Nutritional Compositions
EP2588070B8 (en) USE OF CHICORIC ACID AND LACTIC BACTERIUM IN FOOD SUPPLEMENT FOR lightening and/or whitening skin tone
BR112013027474A2 (en) compositions that improve palatability
PH12013500917A1 (en) Use of nutritional compositions including lactoferrin in supporting resistance to diseases and conditions
WO2011136573A3 (en) Yeast hydrolysate having obesity treatment effects and antioxidant activity
WO2010119424A3 (en) Composition for regulating the metabolism of lipids
PH12013500761A1 (en) Cysteine and food intake
AU2011343331A8 (en) Compositions based on clay and bee pollen, method for preparing same, and nutritional and therapeutic uses thereof
MX2014001767A (en) Methods for ameliorating symptoms or conditions caused by stress.

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 201180063052.8

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11809005

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 12013500916

Country of ref document: PH

WWE Wipo information: entry into national phase

Ref document number: 001284-2013

Country of ref document: PE

WWE Wipo information: entry into national phase

Ref document number: MX/A/2013/006094

Country of ref document: MX

WWE Wipo information: entry into national phase

Ref document number: 2011809005

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2822892

Country of ref document: CA

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 13163728

Country of ref document: CO

ENP Entry into the national phase

Ref document number: 2013128920

Country of ref document: RU

Kind code of ref document: A

REG Reference to national code

Ref country code: BR

Ref legal event code: B01A

Ref document number: 112013011642

Country of ref document: BR

ENP Entry into the national phase

Ref document number: 112013011642

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20130510